Oral High-Dose Multivitamins and Minerals After Myocardial Infarction: A Randomized Trial

18.12.20131573
Whether high-dose multivitamins are effective for secondary prevention of atherosclerotic disease is unknown.

Should axis deviation or atrial enlargement be categorised as abnormal in young athletes? The athlete's electrocardiogram: time for re-appraisal of markers of pathology

17.12.20131657
The 2010 European Society of Cardiology (ESC) guidelines for electrocardiogram (ECG) interpretation in athletes are associated with a relatively high false positive rate and warrant modification to improve the specificity without compromising sensitivity.

Do Younger Women Fare Worse? Sex Differences in Acute Myocardial Infarction Hospitalization and Early Mortality Rates Over Ten Years

16.12.20131460
Recent research has identified younger women as an “at-risk” population with rising prevalence of cardiac risk factors and excess mortality risk following acute myocardial infarction (AMI).

Allopurinol Reduces Left Ventricular Mass in Patients With Type 2 Diabetes and Left Ventricular Hypertrophy

13.12.20131575
This study sought to ascertain whether high-dose allopurinol causes regression of left ventricular mass (LVM) in patients with type 2 diabetes mellitus (T2DM).

Study Finds Biomaterials Repair Human Heart

12.12.20131528
Clemson University biological sciences student Meghan Stelly and her father, Alabama cardiovascular surgeon Terry Stelly, investigated a biomedical application following a coronary artery bypass surgery and found that the application allowed the human body to regenerate its own tissue.

Growth Properties of Cardiac Stem Cells Are a Novel Biomarker of Patients’ Outcome After Coronary Bypass Surgery

11.12.20131658
Does the growth reserve of cardiac stem cells (CSCs) and circulating cytokines promoting CSC activation impact ventricular remodeling in patients with coronary artery disease?

High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality

10.12.20131524
High-density lipoprotein (HDL) cholesterol is a strong predictor of cardiovascular mortality.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.